0001493152-22-021321.txt : 20220804
0001493152-22-021321.hdr.sgml : 20220804
20220804161611
ACCESSION NUMBER: 0001493152-22-021321
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220711
FILED AS OF DATE: 20220804
DATE AS OF CHANGE: 20220804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Poirier Michael S.
CENTRAL INDEX KEY: 0001812504
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37428
FILM NUMBER: 221136782
MAIL ADDRESS:
STREET 1: 2042 CORTE DEL NOGAL
STREET 2: SUITE B
CITY: CARLSBAD
STATE: CA
ZIP: 92011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001460702
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263474527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2042 CORTE DEL NOGAL
STREET 2: CARLSBAD
CITY: CALIFORNIA
STATE: CA
ZIP: 92011
BUSINESS PHONE: (760) 918-9165
MAIL ADDRESS:
STREET 1: 2042 CORTE DEL NOGAL
STREET 2: CARLSBAD
CITY: CALIFORNIA
STATE: CA
ZIP: 92011
FORMER COMPANY:
FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20090402
4
1
ownership.xml
X0306
4
2022-07-11
0
0001460702
Qualigen Therapeutics, Inc.
QLGN
0001812504
Poirier Michael S.
C/O QUALIGEN THERAPEUTICS, INC.,
2042 CORTE DEL NOGAL
CARLSBAD
CA
92011
1
1
0
0
Chairman and CEO
Stock Option (Right to Buy)
0.5136
2022-07-11
4
A
0
375000
0
A
2032-07-11
Common Stock
375000
375000
D
Shares underlying the stock option vest over three years in equal annual installments from the date of grant.
/s/ Michael S. Poirier
2022-08-04